menu
European Commission
This project has received funding from the
European Union’s Seventh Framework Programme
for research, technological development and demonstration.
agence de communication Lyon
menu

    TumAdoR PROJECT

    Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context

    Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising

    Events
    News

    15 December 2015 M30 meeting in San Antonio

    We had a green ligh to meet in Texas! The meeting will be organized by UTHSCSA on 9 and 10th of March 2016.More >>


    08 September 2015 M24 meeting in München

    Genewake organizes its The TumAdoR M24 meeting in München (Germany), on 9 and 10 September 2015. Program here.More >>


    Displaying results 5 to 6 out of 8
    Brochure